Page 44 - ARNM-2-3

Advances in Radiotherapy
& Nuclear Medicine Molecular imaging of lung cancer

doi: 10.1016/j.crad.2021.05.015 107. Cox TR. The matrix in cancer. Nat Rev Cancer.
2021;21(4):217-238.
96. Ohno Y, Takenaka D, Yoshikawa T, et al. Efficacy of ultrashort
echo time pulmonary MRI for lung nodule detection and doi: 10.1038/s41568-020-00329-7
lung-RADS classification. Radiology. 2022;302(3):697-706.
108. Wynn TA, Ramalingam TR. Mechanisms of fibrosis:
doi: 10.1148/radiol.211254 Therapeutic translation for fibrotic disease. Nat Med.
2012;18(7):1028-1040.
97. Voskrebenzev A, Vogel‐Claussen J. Proton MRI of the lung:
How to tame scarce protons and fast signal decay. J Magn doi: 10.1038/nm.2807
Reson Imaging. 2021;53(5):1344-1357.
109. Xu S, Xu H, Wang W, et al. The role of collagen in cancer:
doi: 10.1002/jmri.27122 From bench to bedside. J Transl Med. 2019;17:1-22.
98. Stecker IR, Freeman MS, Sitaraman S, et al. Preclinical MRI 110. Scodellaro R, Bouzin M, Mingozzi F, et al. Whole-section
to quantify pulmonary disease severity and trajectories in tumor micro-architecture analysis by a two-dimensional
poorly characterized mouse models: A pedagogical example phasor-based approach applied to polarization-dependent
using data from novel transgenic models of lung fibrosis. second harmonic imaging. Front Oncol. 2019;9:527.
J Magn Reson Open. 2021;6:100013.
doi: 10.3389/fonc.2019.00527
99. Babin AL, Cannet C, Gérard C, et al. Bleomycin‐induced 111. Martins Cavaco AC, Dâmaso S, Casimiro S, Costa L.
lung injury in mice investigated by MRI: Model assessment Collagen biology making inroads into prognosis and
for target analysis. Magn Reson Med. 2012;67(2):499-509.
treatment of cancer progression and metastasis. Cancer
doi: 10.1016/j.jmro.2021.100013 Metastasis Rev. 2020;39:603-623.
100. Wahsner J, Gale EM, Rodríguez-Rodríguez A, Caravan P. doi: 10.1007/s10555-020-09888-5
Chemistry of MRI contrast agents: Current challenges and 112. Kinoshita T, Goto T. Molecular mechanisms of pulmonary
new frontiers. Chem Rev. 2018;119(2):957-1057.
fibrogenesis and its progression to lung cancer: A review. Int
doi: 10.1021/acs.chemrev.8b00363 J Mol Sci. 2019;20(6):1461.
101. Li D, Kirberger M, Qiao J, et al. Protein MRI contrast agents doi: 10.3390/ijms20061461
as an effective approach for precision molecular imaging. 113. de Sousa VML, Carvalho L. Heterogeneity in lung cancer.
Invest Radiol. 2024;59(2):170-186.
Pathobiology. 2018;85(1-2):96-107.
doi: 10.1097/RLI.0000000000001057
doi: 10.1159/000487440
102. Pauls S, Mottaghy FM, Schmidt SA, et al. Evaluation of lung 114. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer:
tumor perfusion by dynamic contrast-enhanced MRI. Magn diagnosis and management. Am Fam Physician.
Reson Imaging. 2008;26(10):1334-1341. 2007;75(1):56-63.
doi: 10.1016/j.mri.2008.04.005 115. Chong IW, Chang MY, Chang HC, et al. Great potential of
103. Pauls S, Breining T, Muche R, et al. The role of dynamic, a panel of multiple hMTH1, SPD, ITGA11 and COL11A1
contrast-enhanced MRI in differentiating lung tumor markers for diagnosis of patients with non-small cell lung
subtypes. Clin Imaging. 2011;35(4):259-265. cancer. Oncol Rep. 2006;16(5):981-988.
doi: 10.1016/j.clinimag.2010.07.002 116. Shen L, Yang M, Lin Q, Zhang Z, Zhu B, Miao C. COL11A1
is overexpressed in recurrent non-small cell lung cancer and
104. Thangudu S, Yu CC, Lee CL, Liao MC, Su CH. Magnetic, promotes cell proliferation, migration, invasion and drug
biocompatible FeCO3 nanoparticles for T2-weighted resistance. Oncol Rep. 2016;36(2):877-885.
magnetic resonance imaging of in vivo lung tumors.
J Nanobiotechnology. 2022;20(1):157. doi: 10.3892/or.2016.4869
doi: 10.1186/s12951-022-01355-3 117. Yi X, Luo L, Zhu Y, et al. SPP1 facilitates cell migration and
invasion by targeting COL11A1 in lung adenocarcinoma.
105. Wahyudi H, Reynolds AA, Li Y, Owen SC, Yu SM. Targeting Cancer Cell Int. 2022;22(1):324.
collagen for diagnostic imaging and therapeutic delivery.
J Control Release. 2016;240:323-331. doi: 10.1186/s12935-022-02749-x
doi: 10.1016/j.jconrel.2016.01.007 118. Jin Y, Zhu H, Cai W, et al. B-Myb is up-regulated and
promotes cell growth and motility in non-small cell lung
106. Erstad DJ, Sojoodi M, Taylor MS, et al. Fibrotic response to cancer. Int J Mol Sci. 2017;18(6):860.
neoadjuvant therapy predicts survival in pancreatic cancer
and is measurable with collagen-targeted molecular MRI. doi: 10.3390/ijms18060860
Clin Cancer Res. 2020;26(18):5007-5018. 119. Turkowski K, Herzberg F, Günther S, et al. Fibroblast growth
doi: 10.1158/1078-0432.CCR-18-1359 factor-14 acts as tumor suppressor in lung adenocarcinomas.

Volume 2 Issue 3 (2024) 12 doi: 10.36922/arnm.4173